Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jenner

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Journal of Parkinson'S Disease|August 14, 2013
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesisPeter Jenner, Huw R Morris, Trevor W Robbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigationLance A Smith, Banu C Tel, Michael J Jackson, et al.
Journal of Parkinson'S Disease|May 24, 2020
Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson's DiseaseDaniel J van Wamelen, Raquel N Taddei, Alexander Calvano, et al.
NPJ Parkinson'S Disease|January 22, 2021
Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primateErika Coletto, Iain R Tough, Sara Pritchard, et al.
NPJ Parkinson'S Disease|June 25, 2019
Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's diseaseErika Coletto, John S Dolan, Sara Pritchard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 8, 2009
The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopaMichael John Jackson, Terrance H Andree, Matthew Hansard, et al.
Biochemical and Biophysical Research Communications|September 6, 2005
Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidantsManal M Abd El Mohsen, Mahmoud M Iravani, Jeremy P E Spencer, et al.
Infection and Immunity|October 27, 2004
Antimycobacterial calixarenes enhance innate defense mechanisms in murine macrophages and induce control of Mycobacterium tuberculosis infection in miceM Joseph Colston, Helen C Hailes, Evangelos Stavropoulos, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 2, 2019
Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusersAndres Asser, Atsuko Hikima, Mari Raki, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropiniroleMark J Millan, Benjamin Di Cara, Michael Hill, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Journal of Parkinson'S Disease|August 14, 2013
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesisPeter Jenner, Huw R Morris, Trevor W Robbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigationLance A Smith, Banu C Tel, Michael J Jackson, et al.
Journal of Parkinson'S Disease|May 24, 2020
Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson's DiseaseDaniel J van Wamelen, Raquel N Taddei, Alexander Calvano, et al.
NPJ Parkinson'S Disease|January 22, 2021
Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primateErika Coletto, Iain R Tough, Sara Pritchard, et al.
NPJ Parkinson'S Disease|June 25, 2019
Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's diseaseErika Coletto, John S Dolan, Sara Pritchard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 8, 2009
The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopaMichael John Jackson, Terrance H Andree, Matthew Hansard, et al.
Biochemical and Biophysical Research Communications|September 6, 2005
Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidantsManal M Abd El Mohsen, Mahmoud M Iravani, Jeremy P E Spencer, et al.
Infection and Immunity|October 27, 2004
Antimycobacterial calixarenes enhance innate defense mechanisms in murine macrophages and induce control of Mycobacterium tuberculosis infection in miceM Joseph Colston, Helen C Hailes, Evangelos Stavropoulos, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 2, 2019
Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusersAndres Asser, Atsuko Hikima, Mari Raki, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropiniroleMark J Millan, Benjamin Di Cara, Michael Hill, et al.
Pageof 18